SLC7A5 and lip and oral cavity carcinoma: Concerning other pathways, LAT1 inhibition by the same compound induced cell cycle arrest at G1 phase in oral cancer cells by inhibiting the cyclin D2-cyclin-dependent protein kinase 6 (CDK6) complex and increasing p27 expression, a CDK inhibitor [98].